Related Experiment Video
Updated: Oct 30, 2025

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing
Published on: August 24, 2017
cfDNA Sequencing: Technological Approaches and Bioinformatic Issues
Elodie Bohers1, Pierre-Julien Viailly1, Fabrice Jardin1
1INSERM U1245, Henri Becquerel Center, IRIB, Normandy University, 76000 Rouen, France.
Abstract:
In the era of precision medicine, it is crucial to identify molecular alterations that will guide the therapeutic management of patients. In this context, circulating tumoral DNA (ctDNA) released by the tumor in body fluids, like blood, and carrying its molecular characteristics is becoming a powerful biomarker for non-invasive detection and monitoring of cancer. Major recent technological advances, especially in terms of sequencing, have made possible its analysis, the challenge still being its reliable early detection. Different parameters, from the pre-analytical phase to the choice of sequencing technology and bioinformatic tools can influence the sensitivity of ctDNA detection.
Insights
Circulating tumoral DNA (ctDNA) is a promising biomarker for non-invasive cancer detection and monitoring. Optimizing ctDNA analysis through careful selection of sequencing technology and bioinformatics is key for reliable early cancer detection.
Area of Science:
- Biomarkers
- Molecular Diagnostics
- Oncology
Background:
- Precision medicine relies on identifying molecular alterations for targeted cancer therapy.
- Circulating tumoral DNA (ctDNA), shed by tumors into bodily fluids, offers a non-invasive window into a patient's cancer.
- ctDNA analysis is crucial for early cancer detection and monitoring treatment response.
Purpose of the Study:
- To highlight the significance of ctDNA as a biomarker in precision oncology.
- To discuss the technological advancements enabling ctDNA analysis.
- To identify key factors influencing the sensitivity of ctDNA detection.
Main Methods:
- Review of recent technological advancements in sequencing for ctDNA analysis.
- Discussion of pre-analytical factors affecting ctDNA detection.
- Evaluation of bioinformatic tools for ctDNA analysis.
Main Results:
- ctDNA analysis has advanced significantly due to next-generation sequencing technologies.
- Sensitivity of ctDNA detection is highly dependent on pre-analytical procedures.
- Bioinformatic approaches play a critical role in maximizing ctDNA detection sensitivity.
Conclusions:
- ctDNA is a powerful tool for non-invasive cancer detection and monitoring in precision medicine.
- Reliable early detection of cancer via ctDNA requires optimization across the entire analytical pipeline.
- Further refinement of sequencing and bioinformatics is essential for unlocking the full potential of ctDNA.
Related Concept Videos
RNA-seq
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Sanger Sequencing
Maxam-Gilbert Sequencing
Challenges of the Maxam-Gilbert Method
The...
Genomics

